Two vaccines for coronavirus, bodily fluid Institute’s Covishield and India Biotech’s Covaxin, received emergency approval from the country’s drug regulator these days. After the Drug Controller General of Asian country (DCGI) on Sunday approved the emergency use of each Oxford-AstraZeneca’s Covishield and India Biotech’s Covaxin for immunization against Covid-19 in India, Prime Minister Narendra Modi tweeted that the each Republic …
Read More »